Healthcare · Vaccine antigens production

Vaccine antigens production in Malaysia in 2026

In 2026, Malaysia recorded zero production of vaccine antigens (5 million doses), ranking 33-th out of 197 countries. This gap reflects the nation's current lack of dedicated facilities for synthesizing active pharmaceutical ingredients for vaccines. Nevertheless, Malaysia is far from a biotech backwater: it has carved a strong niche in contract manufacturing of finished dosage forms and is a regional leader in vaccine fill-and-finish operations. Government incentives are now steering investment toward domestic R&D and upstream production, aiming to close the antigen gap in the coming decade.

Data for 2026 · unit: million doses
Position

Malaysia world ranking

#33 / 197

Country position on the scale from last to first place for this indicator.

MY
#33
#197#1
Trend

Change over time

Change in indicator over the available period.

1
1950
2
1990
5
2000
5
2010
10
2020
5
2025
5
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Malaysia — how much?
Based on 2026 data — 5 million doses. This is rank #33 out of 197 countries.
What is Malaysia's rank by Vaccine antigens production?
Malaysia ranks #33 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Malaysia?
Over the available period the indicator changed from 1 to 5 million doses.